Self-Care Medical Devices One Step Closer To Four-Year MDR Extension
Executive Summary
Members of the European Parliament will soon decide whether to grant self-care medical devices such as nasal sprays and throat lozenges the same four-year extension as high-risk devices under the new EU Medical Devices Regulation implementation rules.
You may also be interested in...
All Upgraded Class I Devices Could Benefit From 4-Year Extension As Corrigendum Details Emerge
The text of the EU’s proposed second corrigendum to the Medical Device Regulation is available. It promises to lift the pressure on notified bodies and manufacturers alike.
Self-Care Devices May See Extension After EU Commission Admits MDR ‘Inconsistencies’
Self-care medical devices may be included in the four-year “grace period” following implementation of the new EU Medical Device Regulation as part of an incoming corrigendum to the law, a spokesperson for the European Commission suggested at a recent AESGP meeting.
Over The Counter 2 Apr 2024: Analyzing The Spin-Out Trend In Consumer Health, With HBW’s Malcolm Spicer And Tom Gallen
In this episode, HBW Insight’s Europe and US editors bring their expertise to bear on the current the trend towards standalone OTC companies in global consumer health. We look at four major players: Haleon, which separated from GSK almost two years ago; Kenvue, soon to celebrate its first anniversary as a new company; Sanofi Consumer Healthcare, which is poised to split from its pharma parent; and Bayer, which has decided to buck the trend, holding on to its consumer health division. We discuss some of the advantages of becoming a standalone company, for example in leaning into a wider concept of self-care.